Published in J Am Heart Assoc on August 24, 2012
Comparisons between novel oral anticoagulants and vitamin K antagonists in patients with CKD. J Am Soc Nephrol (2014) 1.57
Interleukin-6 Is a Risk Factor for Atrial Fibrillation in Chronic Kidney Disease: Findings from the CRIC Study. PLoS One (2016) 1.48
Incident atrial fibrillation and risk of death in adults with chronic kidney disease. J Am Heart Assoc (2014) 0.83
Association of Sleep Apnea and Snoring With Incident Atrial Fibrillation in the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol (2015) 0.80
Circulating fibroblast growth factor-23 and the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities study. J Am Heart Assoc (2014) 0.78
Intersection of cardiovascular disease and kidney disease: atrial fibrillation. Curr Opin Nephrol Hypertens (2014) 0.76
Anemia: An Independent Predictor Of Adverse Outcomes In Older Patients With Atrial Fibrillation. J Atr Fibrillation (2016) 0.75
Management of Atrial Fibrillation in Patients With Kidney Disease. J Atr Fibrillation (2014) 0.75
Renal Impairment and Prognosis of Patients with Atrial Fibrillation Undergoing Coronary Intervention - The AFCAS Trial. PLoS One (2015) 0.75
Epidemiologic insights on the role of fibroblast growth factor 23 in cardiovascular disease. Curr Opin Nephrol Hypertens (2015) 0.75
Surgeon preference of surgical approach for partial nephrectomy in patients with baseline chronic kidney disease: a nationwide population-based analysis in the USA. Int Urol Nephrol (2017) 0.75
Precision of pulmonary vein diameter measurements assessed by CE-MRA and steady-state-free precession imaging. Eur Radiol (2012) 0.75
Heart Failure Increases the Risk of Adverse Renal Outcomes in Patients With Normal Kidney Function. Circ Heart Fail (2017) 0.75
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med (2004) 49.19
Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation (1998) 19.93
Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol (1998) 6.76
Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol (2004) 5.23
Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med (1998) 3.79
Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int (2011) 3.48
Mortality risk stratification in chronic kidney disease: one size for all ages? J Am Soc Nephrol (2006) 2.78
Identification of individuals with CKD from Medicare claims data: a validation study. Am J Kidney Dis (2005) 2.65
Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study. Circulation (2011) 2.64
The increasing prevalence of atrial fibrillation among hemodialysis patients. J Am Soc Nephrol (2011) 2.61
Elevated relative mortality risk with mild-to-moderate chronic kidney disease decreases with age. Nephrol Dial Transplant (2007) 1.86
Sympathetic activation in chronic renal failure. J Am Soc Nephrol (2008) 1.80
Atrial fibrillation and stroke in the general medicare population: a 10-year perspective (1992 to 2002). Stroke (2006) 1.76
Blood pressure and mortality in an older population. A 5-year follow-up of the Helsinki Ageing Study. Eur Heart J (1997) 1.75
Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation. J Am Coll Cardiol (2004) 1.72
Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence. Eur Heart J (2005) 1.71
Association of chronic kidney disease with atrial fibrillation among adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Circ Arrhythm Electrophysiol (2010) 1.51
Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients. Am J Kidney Dis (2008) 1.46
Current perceptions of the epidemiology of atrial fibrillation. Cardiol Clin (2009) 1.38
Dilemmas in the management of atrial fibrillation in chronic kidney disease. J Am Soc Nephrol (2008) 1.30
Prevalence of atrial fibrillation and its predictors in nondialysis patients with chronic kidney disease. Clin J Am Soc Nephrol (2009) 1.27
Outcomes associated with race in males with nondialysis-dependent chronic kidney disease. Clin J Am Soc Nephrol (2009) 1.16
Effects of beta-adrenergic antagonists in patients with chronic kidney disease: a systematic review and meta-analysis. J Am Coll Cardiol (2011) 1.16
Warfarin in atrial fibrillation patients with moderate chronic kidney disease. Clin J Am Soc Nephrol (2011) 1.15
Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patients. J Hypertens (2010) 1.11
Chronic kidney disease and CHADS(2) score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation. Am J Cardiol (2011) 1.01
Statin therapy for the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials. Pharmacotherapy (2011) 0.85
Effect of spironolactone on patients with atrial fibrillation and structural heart disease. Clin Cardiol (2011) 0.83
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med (2012) 8.88
Genome sequence of Streptococcus mutans UA159, a cariogenic dental pathogen. Proc Natl Acad Sci U S A (2002) 8.25
'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis (2012) 5.70
Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol (2004) 4.79
Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation (2002) 3.74
Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med (2002) 3.71
Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics. Kidney Int (2010) 3.34
Excerpts from the US Renal Data System 2009 Annual Data Report. Am J Kidney Dis (2010) 3.11
Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction. Arch Intern Med (2008) 2.99
US Renal Data System 2010 Annual Data Report. Am J Kidney Dis (2011) 2.90
Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States. Am J Kidney Dis (2005) 2.81
Differences in diabetes prevalence, incidence, and mortality among the elderly of four racial/ethnic groups: whites, blacks, hispanics, and asians. Diabetes Care (2004) 2.80
US Renal Data System 2013 Annual Data Report. Am J Kidney Dis (2014) 2.68
Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol (2008) 2.65
US Renal Data System 2012 Annual Data Report. Am J Kidney Dis (2013) 2.54
Long-term survival and repeat coronary revascularization in dialysis patients after surgical and percutaneous coronary revascularization with drug-eluting and bare metal stents in the United States. Circulation (2013) 2.47
Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 study. Kidney Int (2005) 2.45
Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study. Kidney Int (2002) 2.36
Chronic kidney disease and cardiovascular disease in the Medicare population. Kidney Int Suppl (2003) 2.20
Excerpts from the United States Renal Data System 2006 Annual Data Report. Am J Kidney Dis (2007) 2.16
United States Renal Data System 2008 Annual Data Report. Am J Kidney Dis (2009) 2.14
Iso-osmolar radio contrast iodixanol in patients with chronic kidney disease. J Invasive Cardiol (2005) 2.06
Acute myocardial infarction: what's in a name? Ann Intern Med (2015) 2.05
Excerpts from the United States Renal Data System 2007 annual data report. Am J Kidney Dis (2008) 2.01
Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. Clin Chem (2004) 2.01
Assessment of left ventricular function by intensivists using hand-held echocardiography. Chest (2009) 1.93
Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States. Am J Kidney Dis (2011) 1.92
Atrial fibrillation and stroke in the general medicare population: a 10-year perspective (1992 to 2002). Stroke (2006) 1.76
Excerpts from the United States Renal Data System 2003 Annual Data Report: atlas of end-stage renal disease in the United States. Am J Kidney Dis (2003) 1.70
Utilization and costs of cardiovascular disease medications in dialysis patients in Medicare Part D. Am J Kidney Dis (2011) 1.63
Smoking and cardiovascular outcomes in dialysis patients: the United States Renal Data System Wave 2 study. Kidney Int (2003) 1.58
Improving ascertainment of sudden cardiac death in patients with end stage renal disease. Clin J Am Soc Nephrol (2011) 1.56
Trends in hip fracture rates in US hemodialysis patients, 1993-2010. Am J Kidney Dis (2013) 1.54
Phosphorus levels are associated with subclinical atherosclerosis in the general population. Atherosclerosis (2008) 1.48
The safety of deFinity and Optison for ultrasound image enhancement: a retrospective analysis of 78,383 administered contrast doses. J Am Soc Echocardiogr (2008) 1.46
Cardiovascular disease in pediatric chronic dialysis patients. Kidney Int (2002) 1.45
Safety of abciximab in patients with chronic renal insufficiency who are undergoing percutaneous coronary interventions. Am Heart J (2003) 1.41
Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney Int (2005) 1.41
Exploratory study of relationship between hospitalized heart failure patients and chronic renal replacement therapy. Nephrol Dial Transplant (2009) 1.40
Kidney disease in cardiology. Nephrol Dial Transplant (2007) 1.38
Cardiac rehabilitation and survival of dialysis patients after coronary bypass. J Am Soc Nephrol (2006) 1.28
Anticoagulants in atrial fibrillation patients with chronic kidney disease. Nat Rev Nephrol (2012) 1.23
Incidence of stroke before and after dialysis initiation in older patients. J Am Soc Nephrol (2013) 1.18
Differences between blacks and whites in the incidence of end-stage renal disease and associated risk factors. Adv Ren Replace Ther (2004) 1.16
Warfarin in atrial fibrillation patients with moderate chronic kidney disease. Clin J Am Soc Nephrol (2011) 1.15
Risk-stratified screening for ischemic heart disease in kidney transplant candidates. Transplantation (2005) 1.15
The report of a national conference on the wait list for kidney transplantation. Am J Transplant (2003) 1.14
Improved long-term survival of dialysis patients after near-total parathyroidectomy. J Am Coll Surg (2012) 1.10
Long-term follow-up of patients undergoing postconditioning during ST-elevation myocardial infarction. J Cardiovasc Transl Res (2010) 1.10
Impact of congestive heart failure, chronic kidney disease, and anemia on survival in the Medicare population. J Card Fail (2004) 1.06
Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction. J Am Coll Cardiol (2005) 1.05
Hypertension in pediatric long-term hemodialysis patients in the United States. Clin J Am Soc Nephrol (2009) 1.04
Pathophysiology of the cardiorenal syndromes: executive summary from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol (2013) 1.03
Peripheral artery disease and CKD: a focus on peripheral artery disease as a critical component of CKD care. Am J Kidney Dis (2012) 1.02
Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial. Nephrol Dial Transplant (2012) 1.01
Quantifying a rare disease in administrative data: the example of calciphylaxis. J Gen Intern Med (2014) 1.01
Long-term survival of dialysis patients with bacterial endocarditis undergoing valvular replacement surgery in the United States. Circulation (2013) 1.00
The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: the EVOLVE trial. J Clin Endocrinol Metab (2013) 0.98
Outcomes of renal transplant and waiting list patients with bacterial endocarditis in the United States. Nephrol Dial Transplant (2008) 0.98
Long-term survival of incident hemodialysis patients who are hospitalized for congestive heart failure, pulmonary edema, or fluid overload. Clin J Am Soc Nephrol (2007) 0.97
Survival of kidney transplantation patients in the United States after cardiac valve replacement. Circulation (2010) 0.96
Cardiac medications and their association with cardiovascular events in incident dialysis patients: cause or effect? Kidney Int (2004) 0.95
Predialysis systolic BP variability and outcomes in hemodialysis patients. J Am Soc Nephrol (2014) 0.95
Survival of patients on dialysis having off-pump versus on-pump coronary artery bypass surgery in the United States. J Thorac Cardiovasc Surg (2009) 0.95
Temporal trends in ischemic stroke and anticoagulation therapy among Medicare patients with atrial fibrillation: a 15-year perspective (1992-2007). JAMA Intern Med (2013) 0.94
Diagnosis and therapy of coronary artery disease in renal failure, end-stage renal disease, and renal transplant populations. Am J Med Sci (2003) 0.94
Prevalence of anemia in erythropoietin-treated pediatric as compared to adult chronic dialysis patients. Kidney Int (2004) 0.93
Serum phosphate and left ventricular hypertrophy in young adults: the coronary artery risk development in young adults study. Kidney Blood Press Res (2009) 0.93
Sudden cardiac arrest in hemodialysis patients with wearable cardioverter defibrillator. Ann Noninvasive Electrocardiol (2013) 0.93
Effects of monthly dose and regular dosing of intravenous active vitamin D use on mortality among patients undergoing hemodialysis. Pharmacotherapy (2009) 0.92
Bidirectional ventricular tachycardia resulting from herbal aconite poisoning. Ann Emerg Med (2005) 0.91
On-pump versus off-pump coronary surgery outcomes in patients requiring dialysis: perspectives from a single center and the United States experience. J Thorac Cardiovasc Surg (2006) 0.89
Risks of death and end-stage renal disease after surgical compared with percutaneous coronary revascularization in elderly patients with chronic kidney disease. Circulation (2012) 0.88
Cardiorenal syndrome type 4: insights on clinical presentation and pathophysiology from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol (2013) 0.88
Can we prevent sudden cardiac death in dialysis patients? Clin J Am Soc Nephrol (2007) 0.87
Association of heart disease with diabetes and hypertension in patients with ESRD. Am J Kidney Dis (2005) 0.87
Cardiac arrest in dialysis patients: taking a small step. Semin Dial (2004) 0.87
Incidence of adverse events associated with use of perflutren contrast agents for echocardiography. JAMA (2008) 0.87
Diagnosis of cardiac disease in pediatric end-stage renal disease. Nephrol Dial Transplant (2010) 0.86
End-stage renal disease: sudden cardiac death: stratifying risk in dialysis patients. Nat Rev Nephrol (2010) 0.86
The spectrum of cardiovascular disease in children with predialysis chronic kidney disease. Adv Chronic Kidney Dis (2004) 0.86
Impact of Centers for Medicare & Medicaid Services national coverage determination on erythropoiesis-stimulating agent and transfusion use in chemotherapy-treated cancer patients. Pharmacoepidemiol Drug Saf (2012) 0.85
Dismal long-term survival of dialysis patients after acute myocardial infarction: can we alter the outcome? Nephrol Dial Transplant (2002) 0.84
Clinical epidemiology of atrial fibrillation and related cerebrovascular events in the United States. Neurologist (2008) 0.83
Comparison of dobutamine stress echocardiography, dobutamine SPECT, and adenosine SPECT myocardial perfusion imaging in patients with end-stage renal disease. J Nucl Cardiol (2009) 0.83
Long-term survival of dialysis patients with bacterial endocarditis in the United States. Am J Kidney Dis (2004) 0.83
Noninvasive evaluation of endolymphatic space in healthy volunteers using magnetic resonance imaging. Acta Otolaryngol (2010) 0.83
Factors associated with bronchiectasis in patients with moderate-severe chronic obstructive pulmonary disease. Medicine (Baltimore) (2016) 0.81
Pharmacotherapy in chronic kidney disease patients presenting with acute coronary syndrome: a scientific statement from the American Heart Association. Circulation (2015) 0.81
XAF1 expression and regulatory effects of somatostatin on XAF1 in prostate cancer cells. J Exp Clin Cancer Res (2010) 0.81
High prevalence of cardiac autonomic dysfunction and T-wave alternans in dialysis patients. Heart Rhythm (2010) 0.81